Our Latest News
Browse our articles and news for unique insights
and actionable tips.
and actionable tips.
Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer
Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens
Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic
Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team
Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
— Dr. Rock to support Cartography in the translation of tumor-specific targets into therapeutics, with initial focus on its lead program for colorectal cancer (CRC) — SOUTH SAN FRANCISCO, February 7, 2024 Cartography Biosciences, an oncology company advancing a...
Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
—Newly appointed members Tara Arvedson, Ph.D., and Janine Schuurman, Ph.D., to support Cartography in the advancement of first-in-class precision cancer immunotherapies— May 31, 2023 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Cartography...